Novartis AG (NOVNEE) - Financials, balance sheet (quarterly)

102.92000 CHF

1.16

1.14%

Last update Sep 3, 4:35 PM CEST

Market closed

Day range

102.92000

101.60000

102.92000

Previous close

101.76000

Open

101.78000

Access this stock data via API

Novartis AG

102.92

1.16

1.14%

Financials

Balance sheet

Fiscal date	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Total assets	84.0B	80.4B	82.2B	83.3B
Current assets	20.9B	20.2B	23.9B	25.1B
Cash	—	—	2.1B	—
Cash equivalents	—	—	7.1B	—
Cash and cash equivalents	5.4B	5.7B	9.2B	10.9B
Other short term investments	276.7M	104.6M	1.5B	330.5M
Accounts receivable	7.3B	6.9B	6.0B	6.4B
Other receivables	—	—	1.2B	—
Inventory	5.1B	4.7B	4.6B	4.8B
Prepaid assets	—	—	792.2M	—
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	85.2M	—
Other current assets	2.8B	2.7B	—	2.5B
Non current assets	63.1B	60.2B	58.3B	58.1B
Properties	9.5B	8.9B	46.6M	9.0B
Land and improvements	—	—	682.0M	—
Machinery furniture equipment	—	—	7.4B	—
Construction in progress	—	—	1.3B	—
Leases	—	—	—	—
Accumulated depreciation	—	—	-8.9B	—
Goodwill	64.6B	62.3B	61.5B	62.5B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	23.5B	22.1B	21.6B	22.4B
Investments and advances	1.7B	1.7B	907.2M	1.8B
Other non current assets	7.8B	7.4B	5.0B	4.9B
Total liabilities	50.1B	49.5B	46.7B	48.3B
Current liabilities	25.5B	25.4B	23.1B	22.6B
Accounts payable	3.6B	3.4B	3.7B	3.3B
Accrued expenses	—	—	1.7B	—
Short term debt	6.9B	6.5B	6.7B	5.5B
Deferred revenue	—	—	102.1M	—
Tax payable	2.3B	2.1B	1.8B	1.7B
Pensions	—	—	2.0B	—
Other current liabilities	12.7B	13.5B	341.0M	12.1B
Non current liabilities	24.6B	24.0B	23.7B	25.7B
Long term provisions	—	—	451.2M	—
Long term debt	19.4B	18.7B	18.4B	20.4B
Provision for risks and charges	—	—	—	—
Deferred liabilities	1.9B	2.0B	1.9B	1.8B
Derivative product liabilities	—	—	—	—
Other non current liabilities	3.4B	3.3B	837.2M	3.5B
Shareholders equity
Common stock	616.0M	616.0M	637.8M	637.8M
Retained earnings	33.4B	32.0B	37.4B	37.2B
Other shareholders equity	-221.2M	-1.8B	-2.6B	-3.0B
Total shareholders equity	33.8B	30.9B	35.5B	34.9B
Additional paid in capital	—	—	—	—
Treasury stock	26.5M	15.3M	42.6M	32.2M
Minority interest	55.5M	66.8M	64.3M	99.7M